vs
STANDARD BIOTOOLS INC.(LAB)与蜗牛(SNAL)财务数据对比。点击上方公司名可切换其他公司
蜗牛的季度营收约是STANDARD BIOTOOLS INC.的1.3倍($25.1M vs $19.6M),蜗牛净利率更高(-3.4% vs -177.4%,领先174.0%),蜗牛同比增速更快(-4.2% vs -11.5%),过去两年蜗牛的营收复合增速更高(33.4% vs -12.2%)
Standard BioTools(原Fluidigm公司)是一家美国生命科学工具企业,主营流式细胞术与组织成像分析用质谱流式系统,以及配套的检测试剂盒与试剂,同时供应自动化基因组分析仪器、各类微流控芯片(又称集成流体电路)及配套试剂耗材,全系列产品及应用场景均可提供定制检测方案与相关服务。
苏州蜗牛数字科技股份有限公司,简称蜗牛,是总部位于苏州的中国游戏企业,同时持有虚拟运营商牌照,旗下拥有蜗牛游戏、蜗牛移动两大业务板块,北美分部负责在美洲及欧洲地区推广旗下游戏产品。蜗牛主营大型多人在线、即时战略与休闲类游戏,全球累计注册用户已超7000万。
LAB vs SNAL — 直观对比
营收规模更大
SNAL
是对方的1.3倍
$19.6M
营收增速更快
SNAL
高出7.3%
-11.5%
净利率更高
SNAL
高出174.0%
-177.4%
两年增速更快
SNAL
近两年复合增速
-12.2%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $19.6M | $25.1M |
| 净利润 | $-34.7M | $-862.2K |
| 毛利率 | 48.5% | 38.3% |
| 营业利润率 | -168.5% | -6.0% |
| 净利率 | -177.4% | -3.4% |
| 营收同比 | -11.5% | -4.2% |
| 净利润同比 | -28.8% | -177.0% |
| 每股收益(稀释后) | $-0.09 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
LAB
SNAL
| Q4 25 | — | $25.1M | ||
| Q3 25 | $19.6M | $13.8M | ||
| Q2 25 | $21.8M | $22.2M | ||
| Q1 25 | $40.8M | $20.1M | ||
| Q4 24 | — | $26.2M | ||
| Q3 24 | $22.1M | $22.5M | ||
| Q2 24 | $22.5M | $21.6M | ||
| Q1 24 | $45.5M | $14.1M |
净利润
LAB
SNAL
| Q4 25 | — | $-862.2K | ||
| Q3 25 | $-34.7M | $-7.9M | ||
| Q2 25 | $-33.5M | $-16.6M | ||
| Q1 25 | $-26.0M | $-1.9M | ||
| Q4 24 | — | $1.1M | ||
| Q3 24 | $-26.9M | $235.1K | ||
| Q2 24 | $-45.7M | $2.3M | ||
| Q1 24 | $-32.2M | $-1.8M |
毛利率
LAB
SNAL
| Q4 25 | — | 38.3% | ||
| Q3 25 | 48.5% | 0.1% | ||
| Q2 25 | 48.8% | 31.3% | ||
| Q1 25 | 48.4% | 29.1% | ||
| Q4 24 | — | 43.3% | ||
| Q3 24 | 54.9% | 38.6% | ||
| Q2 24 | 46.1% | 37.5% | ||
| Q1 24 | 53.1% | 14.7% |
营业利润率
LAB
SNAL
| Q4 25 | — | -6.0% | ||
| Q3 25 | -168.5% | -71.3% | ||
| Q2 25 | -118.1% | -8.2% | ||
| Q1 25 | -80.8% | -20.4% | ||
| Q4 24 | — | 11.5% | ||
| Q3 24 | -120.9% | 1.8% | ||
| Q2 24 | -134.5% | 12.4% | ||
| Q1 24 | -132.2% | -15.6% |
净利率
LAB
SNAL
| Q4 25 | — | -3.4% | ||
| Q3 25 | -177.4% | -56.9% | ||
| Q2 25 | -153.7% | -74.7% | ||
| Q1 25 | -63.8% | -9.7% | ||
| Q4 24 | — | 4.3% | ||
| Q3 24 | -122.0% | 1.0% | ||
| Q2 24 | -203.3% | 10.4% | ||
| Q1 24 | -70.6% | -12.6% |
每股收益(稀释后)
LAB
SNAL
| Q4 25 | — | — | ||
| Q3 25 | $-0.09 | — | ||
| Q2 25 | $-0.09 | $-0.44 | ||
| Q1 25 | $-0.07 | $-0.06 | ||
| Q4 24 | — | $0.03 | ||
| Q3 24 | $-0.07 | $0.01 | ||
| Q2 24 | $-0.12 | $0.06 | ||
| Q1 24 | $-0.27 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $8.6M |
| 总债务越低越好 | — | $14.6M |
| 股东权益账面价值 | $399.7M | $-16.4M |
| 总资产 | $539.6M | $59.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
LAB
SNAL
| Q4 25 | — | $8.6M | ||
| Q3 25 | $129.4M | $12.3M | ||
| Q2 25 | $158.6M | $7.9M | ||
| Q1 25 | $150.9M | $9.4M | ||
| Q4 24 | — | $7.3M | ||
| Q3 24 | $210.6M | $10.6M | ||
| Q2 24 | $269.8M | $15.5M | ||
| Q1 24 | $287.1M | $16.1M |
总债务
LAB
SNAL
| Q4 25 | — | $14.6M | ||
| Q3 25 | — | $10.5M | ||
| Q2 25 | — | $11.8M | ||
| Q1 25 | — | $9.0M | ||
| Q4 24 | — | $5.7M | ||
| Q3 24 | $55.2M | $5.7M | ||
| Q2 24 | $55.1M | $5.8M | ||
| Q1 24 | $55.0M | $6.5M |
股东权益
LAB
SNAL
| Q4 25 | — | $-16.4M | ||
| Q3 25 | $399.7M | $-15.6M | ||
| Q2 25 | $424.5M | $-8.0M | ||
| Q1 25 | $454.6M | $9.1M | ||
| Q4 24 | — | $9.7M | ||
| Q3 24 | $489.3M | $8.2M | ||
| Q2 24 | $510.3M | $7.9M | ||
| Q1 24 | $577.3M | $5.6M |
总资产
LAB
SNAL
| Q4 25 | — | $59.3M | ||
| Q3 25 | $539.6M | $51.1M | ||
| Q2 25 | $557.0M | $58.0M | ||
| Q1 25 | $579.6M | $64.5M | ||
| Q4 24 | — | $62.2M | ||
| Q3 24 | $681.5M | $66.8M | ||
| Q2 24 | $708.7M | $75.4M | ||
| Q1 24 | $777.7M | $78.3M |
负债/权益比
LAB
SNAL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.99× | ||
| Q4 24 | — | 0.59× | ||
| Q3 24 | 0.11× | 0.70× | ||
| Q2 24 | 0.11× | 0.73× | ||
| Q1 24 | 0.10× | 1.16× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $-5.3M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | — |
| 自由现金流率自由现金流/营收 | -118.1% | — |
| 资本支出强度资本支出/营收 | 4.5% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-111.1M | — |
8季度趋势,按日历期对齐
经营现金流
LAB
SNAL
| Q4 25 | — | $-5.3M | ||
| Q3 25 | $-22.2M | $6.6M | ||
| Q2 25 | $-20.7M | $-3.2M | ||
| Q1 25 | $-30.3M | $764.5K | ||
| Q4 24 | — | $-3.6M | ||
| Q3 24 | $-27.9M | $-5.0M | ||
| Q2 24 | $-39.0M | $206.6K | ||
| Q1 24 | $-62.5M | $6.8M |
自由现金流
LAB
SNAL
| Q4 25 | — | — | ||
| Q3 25 | $-23.1M | — | ||
| Q2 25 | $-22.6M | — | ||
| Q1 25 | $-35.3M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-30.1M | — | ||
| Q2 24 | $-41.0M | — | ||
| Q1 24 | $-63.3M | — |
自由现金流率
LAB
SNAL
| Q4 25 | — | — | ||
| Q3 25 | -118.1% | — | ||
| Q2 25 | -103.6% | — | ||
| Q1 25 | -86.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -136.4% | — | ||
| Q2 24 | -182.2% | — | ||
| Q1 24 | -138.9% | — |
资本支出强度
LAB
SNAL
| Q4 25 | — | — | ||
| Q3 25 | 4.5% | — | ||
| Q2 25 | 8.7% | — | ||
| Q1 25 | 12.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 10.2% | — | ||
| Q2 24 | 8.6% | — | ||
| Q1 24 | 1.7% | — |
现金转化率
LAB
SNAL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -3.21× | ||
| Q3 24 | — | -21.05× | ||
| Q2 24 | — | 0.09× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
SNAL
| Pc | $14.7M | 59% |
| Platform Three | $5.2M | 21% |
| Platform Two | $3.3M | 13% |
| Sales Channel Directly To Consumer Mobile Sale | $1.6M | 6% |